Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...

Beyond its primary function in digestion, the stomach secretes various peptides believed to influence numerous physiological processes within the organism. Thes ...

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...

CytomX Therapeutics reveals promising CX-2501 results & strengthens finances with $100M offering. Key updates on cancer ...

In a study published in the Journal of Clinical Investigation, researchers used mouse models and analyses of human colorectal ...

CytomX Therapeutics, Inc.’s CTMX share price has dipped by 9.45%, which has investors questioning if this is right time to ...

CytomX's CX-2051, a PROBODY® EpCAM-targeted antibody-drug conjugate (ADC), showed a 28% confirmed response rate and 5.8-month ...

Certainly, it’s pool time whether at home, public pool or the beach. In fact, many already are sun bathing when they can to ...

The long natural history of colorectal carcinogenesis in humans precludes the ... PUFA administration on putative mucosal biomarkers of future CRC risk, such as epithelial cell mitosis frequency in ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning ...

A new study reveals the shocking relationship between early-onset colorectal cancer and a super common disease that impacts ...

Thetis cells, a class of immune cells first described in 2022, play an essential and previously unknown role in suppressing inflammatory responses to food, a new study finds.